Stockholm - Delayed Quote • SEK
Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
At close: April 25 at 5:29 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 7 | 10 |
| Avg. Estimate | 2.38 | 0.74 | 9.69 | 15.38 |
| Low Estimate | 1.5 | 0.48 | 9.23 | 11.57 |
| High Estimate | 3.6 | 0.89 | 10.81 | 19.58 |
| Year Ago EPS | 4.43 | 0.71 | 8.55 | 9.69 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 12 | 12 |
| Avg. Estimate | 5.63B | 5.06B | 24.08B | 27.16B |
| Low Estimate | 5.22B | 4.74B | 23.06B | 25.66B |
| High Estimate | 5.82B | 5.23B | 25.4B | 28.87B |
| Year Ago Sales | 5.24B | 4.87B | 22.12B | 24.08B |
| Sales Growth (year/est) | 7.50% | 3.90% | 8.80% | 12.80% |
Earnings History
| CURRENCY IN USD | 12/31/2022 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 4.42 | 1.09 | 0.36 | 3.71 |
| EPS Actual | 4.43 | 0.71 | 0.3 | 3.21 |
| Difference | 0.01 | -0.38 | -0.06 | -0.5 |
| Surprise % | 0.20% | -34.90% | -16.70% | -13.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.38 | 0.74 | 9.69 | 15.38 |
| 7 Days Ago | 2.16 | 0.74 | 10.62 | 15.55 |
| 30 Days Ago | 2.21 | 0.7 | 10.63 | 15.61 |
| 60 Days Ago | 2.21 | 0.7 | 11.28 | 16.16 |
| 90 Days Ago | 2.8 | 0.76 | 12 | 16.84 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 2 |
| Up Last 30 Days | -- | 1 | 4 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SOBI.ST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -46.30% | -- | -- | 2.60% |
| Next Qtr. | 4.20% | -- | -- | 13.40% |
| Current Year | 13.30% | -- | -- | 5.20% |
| Next Year | 58.70% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 26.85% | -- | -- | 11.11% |
| Past 5 Years (per annum) | -9.71% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Barclays: Overweight to Equal-Weight | 2/24/2021 |
Related Tickers
BIOG-B.ST BioGaia AB (publ)
113.80
-0.61%
SFZN.SW Siegfried Holding AG
870.00
-0.80%
VV5.F Vext Science, Inc.
0.1590
+3.25%
VEGGD Better Plant Sciences Inc.
0.0100
0.00%
R07.F Rubicon Organics Inc.
0.2460
-2.38%
SPLIF Vertical Peak Holdings Inc.
0.0040
0.00%
CPIVF Captiva Verde Wellness Corp.
0.0100
0.00%
ROMJF Rubicon Organics Inc.
0.2755
+3.53%
ANCR.L Animalcare Group plc
217.00
0.00%
ALM.MC Almirall, S.A.
8.47
+0.95%